Sign up to save your podcasts
Or
Share Post-Vaccine Stock Picks — Is YOUR portfolio ready?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Post-Vaccine Stock Picks — Is YOUR portfolio ready?
The stock market doesn't need a vaccine. It just needs positive news about the possibility of a vaccine. That's what saw Monday. The positive interim phase 1 trial press release from biotech Moderna was a great trial run for investors. Today on Dumb Money Live, what news are we looking for? What stocks will benefit most? And more importantly, how are we are tming our entry points on the next news of a vaccine?
View all episodes
By Dumb Money
4.7
110110 ratings
The stock market doesn't need a vaccine. It just needs positive news about the possibility of a vaccine. That's what saw Monday. The positive interim phase 1 trial press release from biotech Moderna was a great trial run for investors. Today on Dumb Money Live, what news are we looking for? What stocks will benefit most? And more importantly, how are we are tming our entry points on the next news of a vaccine?
More shows like Dumb Money Live
View all
We Study Billionaires - The Investor’s Podcast Network
3,393 Listeners
Rule Breaker Investing
942 Listeners
Chat With Traders
1,986 Listeners
Tom Bilyeu's Impact Theory
4,693 Listeners
FYI - For Your Innovation
393 Listeners
Chit Chat Stocks
195 Listeners
The Pomp Podcast
1,851 Listeners
The Compound and Friends
2,113 Listeners
The Wolf Of All Streets
243 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,822 Listeners
The Iced Coffee Hour
732 Listeners
Raoul Pal: The Journey Man
133 Listeners
Moonshots with Peter Diamandis
539 Listeners
Rich Habits Podcast
468 Listeners
BG2Pod with Brad Gerstner and Bill Gurley
499 Listeners